ResMed’s strong demand for AirSense 11 boosts its earnings outlook. Learn why RMD stock is undervalued with growth ...

ResMed Inc. (NYSE:RMD) Q2 2025 Earnings Call Transcript January 30, 2025 ResMed Inc. beats earnings expectations. Reported EPS is $2.43, expectations were $2.32. Operator: Welcome to the Q2 Fiscal ...

Resmed has its origins in the 1980s, when Sydney sleep expert Dr Colin Sullivan converted a vacuum cleaner to deal with the ...

AirSense 11. Market share gains from Philips’ product recall may be limited as affected customers can wait for a replacement unit, purchase an alternative Philips product, and ResMed’s supply ...

We forecast slight margin expansion as ResMed’s sales mix shifts to higher-margin masks, and the cost inefficiency of simultaneously producing older AirSense 10 devices ceases ... positive airway ...

It is similar in some ways to other therapy modes, including CPAP and bilevel. There are pros and cons ... Also known as APAP, auto-titrating, or by brand names such as AirSense (used by ResMed), ...

Revenue: $1.28 billion, an increase of 10% year-over-year ... and improve patient outcomes. ResMed Inc (NYSE:RMD) is expanding its global reach with the AirSense 11 platform, launching in new ...

ResMed demonstrated solid performance in Q2 FY2025, with a 10% increase in group revenue year-over-year. The company's strategic focus on innovation and digital health solutions appears to be ...

This represents a year-over-year change of 10.2% and 6.54%, respectively. ResMed may be at a 52-week high right now, but what might the future hold for the stock? A key aspect of this question is ...

Below are five key topics to understand about power supply to data centers. Data Centers Have High Around-the-Clock Energy Demand. Data centers consume an immense amount of power. This power usage ...